Arrhythmogenic effects induced by coronary conversion of pulmonary big endothelin to endothelin
Aggravation of this phenomenon in heritable hyperlipidemia
Konstantin Alexiou, MDa,
Thomas Dschietzig, MDa,
Oliver Simscha,
Michael Laule, MDa,
Johannes Hundertmarka,
Gert Baumann, MDa and
Karl Stangl, MDa
a Medizinische Klinik und Poliklinik I, Charité, Humboldt-Universität zu Berlin, D-10098 Berlin, Germany

View larger version (43K):
[in a new window]
|
Figure 1 Incidence of VES during 40 min of separate perfusion and an additional 40 min of serial perfusion in NZW (n = 12) and WHHL (n = 8) rabbits. During serial perfusion, isolated hearts are perfused with the effluent of the same animals isolated lung. To exclude flow-dependency of arrhythmias, mechanical flow reduction (i.e., volume-controlled perfusion) comparable to the effects seen during serial perfusion was performed in isolated NZW and WHHL hearts (M-NZW, New Zealand mechanical flow reduction group; M-WHHL, Watanabe mechanical flow reduction group, n = 6 for both groups). ##, p < 0.01 vs. separate perfusion.
|
|

View larger version (42K):
[in a new window]
|
Figure 2 Incidence of VES in NZW and Watanabe hearts when serial perfusion (40 min) was conducted in the presence of PD-145065 (nonselective ET antagonist, 10 µmol/liter), A-127722 (ETA antagonist, 20 µmol/liter), BQ-123 (ETA antagonist, 2 µmol/liter) and phosphoramidon (Phrd, ECE inhibitor, 50 µmol/liter) (n = 6 per group). #, p < 0.05; ##, p < 0.01 vs. separate perfusion; *, p < 0.05; **, p < 0.01 vs. serial perfusion without intervention.
|
|
|